Grifols Promonitor®

The Promonitor® product portfolio is manufactured by Grifols and distributed by Aidian. Promonitor® biological drug monitoring tests offer key information about drug bioavailability and immunogenicity in patients prescribed with biological therapy for the treatment of chronic inflammatory diseases and other indications.


Promonitor® ELISA tests allow determination of biologic drug concentration and anti-drug antibody level in serum. The following biological treatments can be tested: infliximab, adalimumab, etanercept, rituximab, golimumab, vedolizumab and ustekinumab.


Promonitor® Quick ANTI-IFX, IFX and ADL Real Point-of-Care tests are available to facilitate immediate decisions for treatment management of patients treated with infliximab and adalimumab.

Är du intresserad av de här produkterna?

Är du intresserad av de här produkterna?